O Bairey

Summary

Affiliation: Tel Aviv University
Country: Israel

Publications

  1. ncbi request reprint Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma
    Osnat Bairey
    Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Leuk Lymphoma 44:1733-8. 2003
  2. pmc Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma
    I Pazgal
    Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petah Tiqva, 49100, Israel
    Br J Cancer 86:1770-5. 2002
  3. doi request reprint Early death in patients diagnosed with non-Hodgkin's lymphoma
    Osnat Bairey
    Institute of Hematology, Rabin Medical Center, Petach Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Ann Hematol 92:345-50. 2013
  4. doi request reprint Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group
    Osnat Bairey
    Hematology Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel
    Eur J Haematol 89:491-6. 2012
  5. ncbi request reprint Serum CA 125 levels in patients with chronic lymphocytic leukemia
    O Bairey
    Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petah Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Clin Lab Haematol 27:57-60. 2005
  6. ncbi request reprint Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma
    Osnat Bairey
    Institute of Hematology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Eur J Haematol 76:384-91. 2006
  7. ncbi request reprint Non-Hodgkin's lymphomas of the colon
    Osnat Bairey
    Institute of Hematology, Rabin Medical Center Beilinson Campus, Petah Tiqva, Israel, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
    Isr Med Assoc J 8:832-5. 2006
  8. ncbi request reprint Is bone marrow biopsy obligatory in all patients with non-Hodgkin's lymphoma?
    Osnat Bairey
    Institute of Hematology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Israel
    Acta Haematol 118:61-4. 2007
  9. doi request reprint Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells
    O Bairey
    Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah Tiqwa, Israel
    Int J Lab Hematol 32:e77-85. 2010
  10. doi request reprint Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study
    Osnat Bairey
    Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah Tiqwa, Israel
    Ann Hematol 90:1123-9. 2011

Collaborators

Detail Information

Publications26

  1. ncbi request reprint Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma
    Osnat Bairey
    Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Leuk Lymphoma 44:1733-8. 2003
    ..In conclusion, CA 125 is not only a reliable marker for staging and assessing tumor activity in NHL, elevated levels are also predictive of decreased survival...
  2. pmc Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma
    I Pazgal
    Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petah Tiqva, 49100, Israel
    Br J Cancer 86:1770-5. 2002
    ....
  3. doi request reprint Early death in patients diagnosed with non-Hodgkin's lymphoma
    Osnat Bairey
    Institute of Hematology, Rabin Medical Center, Petach Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Ann Hematol 92:345-50. 2013
    ....
  4. doi request reprint Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group
    Osnat Bairey
    Hematology Institute, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel
    Eur J Haematol 89:491-6. 2012
    ....
  5. ncbi request reprint Serum CA 125 levels in patients with chronic lymphocytic leukemia
    O Bairey
    Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petah Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Clin Lab Haematol 27:57-60. 2005
    ..7%). To conclude, serum CA 125 levels are rarely elevated in CLL patients. It is possible that serum CA 125 levels can help differentiate between equivocal cases of small lymphocytic lymphoma and CLL...
  6. ncbi request reprint Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma
    Osnat Bairey
    Institute of Hematology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Eur J Haematol 76:384-91. 2006
    ....
  7. ncbi request reprint Non-Hodgkin's lymphomas of the colon
    Osnat Bairey
    Institute of Hematology, Rabin Medical Center Beilinson Campus, Petah Tiqva, Israel, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
    Isr Med Assoc J 8:832-5. 2006
    ..Non-Hodgkin's lymphoma of the colon is a rare and consequently poorly studied extranodal lymphoma. Most of the previous publications used old pathologic classifications and old diagnostic and treatment approaches...
  8. ncbi request reprint Is bone marrow biopsy obligatory in all patients with non-Hodgkin's lymphoma?
    Osnat Bairey
    Institute of Hematology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Israel
    Acta Haematol 118:61-4. 2007
    ..We think BMB is not mandatory in every patient with NHL and suggest recommendations for which patients we should continue to perform this procedure on...
  9. doi request reprint Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells
    O Bairey
    Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah Tiqwa, Israel
    Int J Lab Hematol 32:e77-85. 2010
    ..Further studies are needed to elucidate the potential therapeutic role of As(2)O(3) in CLL...
  10. doi request reprint Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study
    Osnat Bairey
    Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah Tiqwa, Israel
    Ann Hematol 90:1123-9. 2011
    ..8, 1.6, and 1.9, respectively). Patients diagnosed with CLL at age ≥80 years may expect to live a long life. This study identifies several factors predicting good prognosis which are easy to obtain...
  11. ncbi request reprint Expression of adhesion molecules on leukemic B cells from chronic lymphocytic leukemia patients with predominantly splenic manifestations
    Osnat Bairey
    Institute of Hematology, Rabin Medical Center Beilinson Campus, Petah Tiqva, Israel
    Isr Med Assoc J 6:147-51. 2004
    ..Among our patients with B cell chronic lymphocytic leukemia 15% demonstrate predominantly splenic manifestations and are classified as stage II(S)...
  12. ncbi request reprint Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide
    Osnat Bairey
    Institute of Hematology, Rabin Medical Center, Beilinson Campus, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Am J Hematol 69:281-4. 2002
    ..Administration of intravenous defibrotide for 19 days induced complete resolution of the VOD. Further consolidation treatment was resumed including high-dose cytosine arabinoside without further complications...
  13. ncbi request reprint All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells
    O Bairey
    Institute of Hematology and the Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus Petah Tikva 49100, Israel
    Leuk Res 28:243-8. 2004
    ..These findings suggest that the VEGF transduction pathway may be very active in CLL cells, and both its paracrine and autocrine pathways may contribute to their enhanced survival...
  14. ncbi request reprint Lack of HER-2/neu expression in Hodgkin and non-Hodgkin lymphoma
    Osnat Bairey
    Institutes of Hematology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Arch Pathol Lab Med 126:574-6. 2002
    ..The significance of HER-2/neu in lymphomas is unknown. The aim of this study was to evaluate the expression of HER-2/neu in the malignant lymphomas: non-Hodgkin and Hodgkin lymphomas...
  15. ncbi request reprint Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia
    O Bairey
    Institute of Haematology and the Felsenstein Medical Research Centre, Rabin Medical Centre, Beilinson Campus, Petah Tikva, Israel
    Br J Haematol 113:400-6. 2001
    ..These findings indicate that in CLL there is a correlation between angiogenesis-related factors and apoptosis-related protein expression, and elevated bFGF levels may account for the elevated Bcl-2 levels...
  16. ncbi request reprint Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease
    A Aviram
    Division of Haematology, Rabin Medical Center, Petach Tikva, Israel
    Eur J Haematol 64:80-4. 2000
    ..058). Of patients in stage C, 45% expressed high levels of both bcl-2 and bax while 50% and 42% of patients at stages A and B had low levels of both proteins...
  17. ncbi request reprint Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas
    O Bairey
    Institute of Hematology, and the Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva, Israel
    Med Oncol 17:314-8. 2000
    ..5 (range 11-94). F8RA appears to be more sensitive for staining DLBC lymphomas microvessels than CD-31. Our data demonstrate that there is no correlation between tumor MVD and response to chemotherapy in patients with DLBC lymphomas...
  18. ncbi request reprint Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient
    E Rabizadeh
    Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Belinson Campus, Petach Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Eur J Haematol 66:263-71. 2001
    ..These results may be beneficial in possible future combination therapy with AN-9 in B-CLL...
  19. ncbi request reprint Non-Hodgkin's lymphoma in patients 80 years of age or older
    O Bairey
    Institute of Hematology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Department of Internal Medicine A, Sapir Medical Center, Kfar Saba, Israel
    Ann Oncol 17:928-34. 2006
    ..Very elderly patients (> or =80 years old) with non-Hodgkin's lymphoma (NHL) frequently have co-morbid conditions and are generally excluded from clinical trials or even from treatment. The optimal treatment of these patients is unknown...
  20. doi request reprint Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma
    Adi Broyde
    Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah Tiqwa, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Am J Hematol 84:338-43. 2009
    ..In diffuse large B-cell lymphoma, a cut-off value of 70% can distinguish patients with a good and bad prognosis when combined with other prognostic factors of low IPI score and bulky disease...
  21. ncbi request reprint Erythropoietin can obviate the need for repeated heart valve replacement in high-risk patients with severe mechanical hemolytic anemia: case reports and literature review
    Y Shapira
    The Dan Sheingarten Echocardiography Unit and Valvular Clinic, Department of Cardiology, Rabin Medical Center, Petah Tiqva, Israel
    J Heart Valve Dis 10:431-5. 2001
    ..CONCLUSION: EPO may defer or even obviate the need for repeated valve surgery in patients with severe hemolysis due to perivalvular leak, especially those with inadequate EPO response, such as those with renal malfunction...
  22. ncbi request reprint Salvage chemotherapy with dexamethasone, etoposide, ifosfamide and cisplatin (DVIP) for relapsing and refractory non-Hodgkin's lymphoma
    Ariela Dortort Lazar
    Institute of Hematology, Rabin Medical Center Beilinson Campus, Petah Tikva, Israel
    Isr Med Assoc J 11:16-22. 2009
    ..There is currently no standard salvage chemotherapy for the 40-50% of patients with non-Hodgkin's lymphoma who fail first-line treatment...
  23. ncbi request reprint Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma
    Chava Perry
    Institute of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    Eur J Haematol 79:205-9. 2007
    ..In the present study, we evaluated the diagnostic accuracy of PET integrated with CT (PETCT) in patients with MALT lymphoma and assessed its reliability in clinical staging and monitoring response...
  24. ncbi request reprint Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia
    Lev Shvidel
    Hematology Institute, Kaplan Medical Center, Rehovot 76100, Israel
    Leuk Lymphoma 44:1947-50. 2003
    ....
  25. ncbi request reprint Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas
    Idit Pazgal
    Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah Tiqwa, Israel
    Leuk Lymphoma 48:2213-20. 2007
    ..Our findings indicate the importance of lymphangiogenic factors in the pathogenesis of DLBCL and suggest a potential therapeutic role for antilymphangiogenesis agents...
  26. ncbi request reprint Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions
    Andres J M Ferreri
    Medical Oncology Unit, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
    Haematologica 92:486-92. 2007
    ..This study explored variations in the clinical manifestations of intravascular lymphoma (IVL) on the bases of the association with hemophagocytosis and the country where the diagnosis was made...